Publication | Closed Access

The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

Heart FailureCardiovascular DiseaseMedicinePhysiologyCardioprotector MonoherCardiovascular PharmacologyCardiologyPharmacotherapyCardiotoxic Agent DoxorubicinCardiovascular PharmacodynamicsCardiovascular ToxicityPharmacologyAtherosclerosis